Five things to watch in markets in the week ahead
MONTPELLIER, France - Medincell (Paris:MEDCL), a biopharmaceutical company with a market capitalization of $755 million and impressive revenue growth of 132% over the last twelve months according to InvestingPro, has appointed three new independent board members at its General Assembly held on Thursday, the company announced in a press release.
The new appointees include Dr. Sharon Mates, co-founder and former CEO of Intra-Cellular Therapies, which was acquired by Johnson & Johnson for $14.6 billion in April 2025; Dr. Charles Kunsch, former Managing Director at AbbVie Ventures; and Dr. Pascal Touchon, who previously held leadership positions at Novartis Oncology and Atara Biotherapeutics.
"We welcome a wealth of additional experience in innovation, strategic vision, and influential networks to our Board," said Philippe Guy, Chairman of Medincell’s Board, according to the statement.
Dr. Mates led the development of CAPLYTA, a therapy for schizophrenia and bipolar depression, during her tenure at Intra-Cellular Therapies. Dr. Kunsch brings over 30 years of experience in R&D and venture capital, having led investments in several biotech companies including Prevail Therapeutics and Tidal Therapeutics. Dr. Touchon has 40 years of international leadership experience and currently serves as an Independent Director at Ipsen and other biotech firms.
The new appointments join existing board members Philippe Guy, CEO Christophe Douat, Elisabeth Kogan, Tone Kvåle, and Virginie Lleu.
Medincell specializes in developing long-acting injectable drugs using its proprietary BEPO technology, which controls drug delivery over extended periods from a single subcutaneous injection. The company maintains a healthy financial position with a current ratio of 2.7, indicating strong liquidity. InvestingPro data reveals 12 additional key insights about the company’s performance and valuation, available to subscribers. The company, based in Montpellier, currently employs more than 140 people representing over 25 nationalities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.